Recombinant Mouse B7-1/CD80 (C-His)

Recombinant Mouse B7-1/CD80 (C-His)

SKU: BP013-50ug
Recombinant Mouse T-lymphocyte Activation Antigen CD80 is produced by our Mammalian expression systemand the target gene encoding Val38-Asn246 is expressed with a 6His tag at the C-terminus.
  • Accession Number

  • Expression

    Human 293 Cells
  • Background

    CD80, also known as B7-1, is a member of cell surface immunoglobulin superfamily. CD80 is predominately expressed on the surface of antigen-presenting cells including activated B cells, macrophages and dendritic cells. CD80 and CD86, together with their receptors CD28 and CTLA4, form one of the dominant co-stimulatory pathways that mediate T- and B- cell responses. Although both CD28 and CTLA4 can bind to CD80 and CD86, CTLA-4 has 20-100 fold higher affinity than CD28 plays a role in the down-regulation of the immune response. CD80 is also involved in the induction of innate immune responses by activating NF-?B-signaling pathway in macrophages. Therefore, CD80 has the potential to be promising therapeutic targets for autoimmune diseases and various carcinomas.
  • Formulation

    Lyophilized frum a 0.2 um filtered solution of PBS, pH7.4
  • Packaging

  • ALTnames

    T-lymphocyte activation antigen CD80; Activation B7-1 antigen; B7; CD80

(800) 943-6396

150 Essex St, Millburn, NJ 07041, USA

©2020 by Bon Opus Biosciences, LLC.